Search Results for “” – Page 11 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Observational Clinical outcomes Change patient management

236 Publications found

MALDI-TOFMS-oriented early definitive therapy improves the optimal use of antibiotics for Enterococcus spp. bloodstream infection.

b

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

February 1, 2021

p MALDI-TOF MS For Microorganism Identification

c Change patient management Clinical outcomes Observational Operational efficiencies
Targeting G1/S phase cell-cycle genomic alterations and accompanying co-alterations with individualized CDK4/6 inhibitor-based regimens.

b

JCI insight

January 11, 2021

p Cancer

c Change patient management Clinical outcomes Highlighted Observational
Prospective identification by neonatal screening of patients with guanidinoacetate methyltransferase deficiency.

b

Molecular genetics and metabolism

January 1, 2021

p Newborn Screening

c Change patient management Clinical outcomes Observational
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer.

b

Therapeutic advances in medical oncology

January 1, 2021

p Cancer

c Change patient management Clinical outcomes Observational
Impact of Precision Medicine on Clinical Outcomes: A Single-Institution Retrospective Study.

b

Frontiers in oncology

January 1, 2021

p Cancer

c Change patient management Clinical outcomes Observational
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.

b

Therapeutic advances in medical oncology

January 1, 2021

p Cancer

c Change patient management Clinical outcomes Observational
A Phase II Trial of Osimertinib as the First-Line Treatment of Non-Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1.

b

Cancer research and treatment

January 1, 2021

p Cancer

c Change patient management Clinical outcomes Observational
Time in blood glucose range 70 to 180 mg/dL and survival rate in critically ill patients: A retrospective cohort study.

b

PloS one

January 1, 2021

p Diabetes

c Change patient management Clinical outcomes Observational
Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial.

b

Investigational new drugs

December 1, 2020

p Cancer

c Change patient management Clinical outcomes Observational
Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M-positive Non-Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study.

b

Clinical cancer research : an official journal of the American Association for Cancer Research

December 1, 2020

p Cancer

c Change patient management Clinical outcomes Observational